Evening-Time Urticaria: Evaluation and Management
Initial Clinical Assessment
Evening-predominant urticaria should be evaluated first by documenting wheal duration and identifying potential physical or cholinergic triggers that peak during evening hours. 1
Key Diagnostic Features to Document
Individual wheal duration is the single most important diagnostic feature: ordinary urticaria wheals last 2–24 hours and resolve without scarring, whereas persistence beyond 24 hours strongly suggests urticarial vasculitis requiring skin biopsy. 1
Evening timing patterns may indicate:
- Cholinergic urticaria triggered by evening activities that raise core body temperature (exercise, hot showers, stress), producing characteristic small itchy wheals within minutes of sweating stimuli 2
- Delayed pressure urticaria developing 2–6 hours after daytime pressure exposure (tight clothing, prolonged sitting), manifesting as evening swelling that fades within 48 hours 1
- Physical urticaria from evening heat exposure, which typically resolves within 1 hour 1
Review photographs of lesions when possible, as this enhances diagnostic accuracy. 1
Laboratory Testing Strategy
No routine laboratory work-up is indicated for acute or episodic urticaria unless the clinical history suggests specific triggers. 1
For chronic urticaria (continuous daily wheals ≥6 weeks), obtain only:
Skin biopsy is mandatory if wheals persist beyond 24 hours to confirm or exclude urticarial vasculitis. 1
First-Line Pharmacologic Management
Second-generation H1 antihistamines at standard doses constitute first-line therapy for all patterns of urticaria. 1
Antihistamine Dosing
Begin with a single daily dose of a non-sedating second-generation H1 antihistamine. 1
If inadequate response after 2 weeks, increase to up to 4-fold the standard dose before adding other agents. 3
Avoid adding first-generation sedating antihistamines at bedtime: a randomized controlled trial demonstrated that adding hydroxyzine 50 mg at night to levocetirizine provides no additional efficacy for urticaria control or sleep quality, but significantly increases daytime somnolence compared to higher-dose levocetirizine monotherapy. 4
Common Pitfall: The Sedating Antihistamine Myth
The widespread practice of adding hydroxyzine or diphenhydramine at bedtime is not evidence-based and worsens daytime function without improving urticaria control. 4
If evening symptoms are particularly severe, increase the morning non-sedating antihistamine dose rather than adding a sedating agent at night. 4
Adjunctive and Second-Line Therapies
Short-Course Oral Corticosteroids
A brief course of oral corticosteroids (e.g., prednisone 40–50 mg daily for 3–5 days with rapid taper) can shorten severe acute episodes. 1
Long-term corticosteroids should be avoided due to toxicity; if required, limit to ≤10 mg daily with weekly 1-mg reductions. 3
Refractory Chronic Spontaneous Urticaria
For patients failing high-dose second-generation antihistamines (up to 4-fold standard dose):
- Omalizumab achieves approximately 75% response rates with the best efficacy-to-toxicity profile and is FDA-approved for chronic spontaneous urticaria. 5, 3
- Cyclosporine also achieves approximately 75% response rates but requires monitoring of blood pressure, urine protein, BUN, and creatinine every 6 weeks. 3
H2 antihistamines and leukotriene antagonists provide minimal additional benefit and should not be routinely added. 4, 3
Trigger Avoidance and Lifestyle Modifications
Avoid aspirin and NSAIDs, which can trigger mast-cell degranulation and worsen urticaria. 1
For evening-predominant symptoms:
- Identify and avoid evening heat exposure (hot showers, heavy exercise, overheating) if cholinergic urticaria is suspected 2
- Minimize daytime pressure from tight clothing or prolonged sitting if delayed pressure urticaria is suspected 1
- Reduce emotional stress and alcohol, which can exacerbate urticaria 1
When to Suspect Alternative Diagnoses
Wheals lasting >24 hours mandate skin biopsy to exclude urticarial vasculitis. 1
Angioedema without wheals requires immediate C4 screening followed by C1-esterase inhibitor quantitative and functional assays if C4 is low. 1
Systemic symptoms (joint pain, fever, fatigue) suggest urticarial vasculitis or autoinflammatory syndromes requiring full vasculitis work-up. 1